logo
Q4 results today: IDFC First Bank, India Cements, Mangalore Refinery, Vakrangee and others to announce earnings

Q4 results today: IDFC First Bank, India Cements, Mangalore Refinery, Vakrangee and others to announce earnings

Business Upturn26-04-2025
The fourth quarter earnings season for FY25 continues to gain momentum as several Indian companies are scheduled to release their financial results on April 26, 2025. Investors, analysts, and market participants will be closely monitoring the numbers to gauge the financial health and performance trajectory of these firms.
Below is the list of companies expected to report their Q4FY25 results today: Companies Releasing Q4FY25 Results – April 26, 2025 ASALCBR (Associated Alcohols & Breweries Ltd)
AVANTEL (Avantel Ltd)
BEPL (Bhansali Engineering Polymers Ltd)
IDFCFIRSTB (IDFC First Bank Ltd)
INDIACEM (The India Cements Ltd)
MANORAMA (Manorama Industries Ltd)
MRPL (Mangalore Refinery and Petrochemicals Ltd)
SBFC (SBFC Finance Ltd)
UGROCAP (UGRO Capital Ltd)
VAKRANGEE (Vakrangee Ltd)
Disclaimer: The above views are based on publicly available information and announcements. They do not constitute investment advice. Please make any and every investment decision after consulting your financial advisor. IDFC First BankIndia CementsMangalore RefineryVakrangee
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Glenmark Pharma to launch Micafungin for Injection USP in the US market
Glenmark Pharma to launch Micafungin for Injection USP in the US market

Business Upturn

timean hour ago

  • Business Upturn

Glenmark Pharma to launch Micafungin for Injection USP in the US market

By Aman Shukla Published on August 19, 2025, 09:52 IST Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial). The product is bioequivalent and therapeutically equivalent to the reference listed drug Mycamine® for Injection by Astellas Pharma US, Inc. (NDA – 021506). The company confirmed that distribution will begin in September 2025. According to IQVIA sales data for the 12-month period ending June 2025, the Mycamine® for Injection market (50 mg/vial and 100 mg/vial) generated approximately $60.7 million in annual sales. Glenmark aims to capture a share of this market by offering a high-quality and more affordable alternative. Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, 'We are excited to introduce Micafungin for Injection USP, further strengthening our institutional product portfolio and reinforcing our commitment to deliver accessible, affordable, and quality medicines to patients in need.' The new launch is expected to expand Glenmark's presence in the U.S. injectable market while enhancing treatment options for patients. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Inox Wind shares jump over 4% after Rs 175 crore stake sale in EPC subsidiary IRSL
Inox Wind shares jump over 4% after Rs 175 crore stake sale in EPC subsidiary IRSL

Business Upturn

timean hour ago

  • Business Upturn

Inox Wind shares jump over 4% after Rs 175 crore stake sale in EPC subsidiary IRSL

By Aman Shukla Published on August 19, 2025, 09:49 IST Inox Wind shares gained more than 4% in early morning trade on Tuesday after the company announced a stake sale worth about ₹175 crore in its subsidiary, Inox Renewable Solutions Ltd. (IRSL). The deal values IRSL, formerly known as Resco Global Wind Services Pvt. Ltd., at nearly ₹7,400 crore. The company said it has divested 49,57,142 equity shares of ₹10 each in IRSL to independent third-party investors through agreements executed on August 18, 2025. Following the transaction, Inox Wind's shareholding in IRSL will reduce from 91.90% to 88.84%. As per the exchange filing under SEBI (LODR) Regulations, IRSL contributed ₹217.98 crore in revenue in FY25, about 6% of Inox Wind's consolidated revenue, and had a net worth of ₹935 crore, accounting for 14% of the parent's consolidated net worth. Inox Wind shares opened at ₹141.00, slightly above its previous close of ₹139.99. During the session, it touched a low of ₹139.28 and climbed to a high of ₹146.94, showing strong intraday volatility. On a broader scale, the company's shares have a 52-week low of ₹128.46 and a high of ₹258.16, reflecting the wide price range it has witnessed over the past year. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Engineers India shares jump 3% after signing agreement with ONGC R&D arm for Helium Recovery Demonstration Plant at Kuthalam
Engineers India shares jump 3% after signing agreement with ONGC R&D arm for Helium Recovery Demonstration Plant at Kuthalam

Business Upturn

timean hour ago

  • Business Upturn

Engineers India shares jump 3% after signing agreement with ONGC R&D arm for Helium Recovery Demonstration Plant at Kuthalam

Engineers India Limited (EIL) shares jumped 3% on Tuesday after Oil and Natural Gas Corporation's research and development arm, ONGC Energy Centre Trust (OECT), signed an agreement with the company to set up a Helium Recovery Demonstration Plant at ONGC's Kuthalam Gas Collection Station in Cauvery Asset, Tamil Nadu. As of 9:32 AM, the shares were trading 2.32% higher at Rs 195.74. The agreement, signed on 18 August 2025, is valued at ₹39.42 crore (plus GST) and covers preparation of the Detailed Project Report (DPR), Basic Engineering Design Package (BEDP), and execution through EPCM and Supply model, including design, procurement, construction, commissioning, and performance testing. The project is scheduled for completion within 18 months. The upcoming demonstration plant will process 750 Nm³/hr of natural gas and is capable of operating at 110% of its design capacity. Developed with CSIR–Indian Institute of Petroleum (CSIR-IIP) technology, the facility will produce Grade-A Helium with 99.995% purity. Helium, widely used in space exploration, semiconductor manufacturing, cryogenics, fibre optics, and medical technologies, is currently imported into India. The project marks a major step in reducing import dependency and aligns with the government's Atmanirbhar Bharat vision by strengthening indigenous capability in high-value gases. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store